AIDS-related Pneumocystis jirovecci pneumonia in an intensive care unit: a descriptive study
Author(s) -
Cecilia Domínguez,
Milagro Sánchez Cunto,
Viviana Chediack,
R. Gregori Sabelli,
Silvia Juliana Trujillo-Cáceres,
L Leal González,
Yésica Lamberto,
Ángel Sánchez,
Paola Lopez,
Elaine Antunes Cortez,
Rocco Romano,
J. Fernandez,
O. López Villar,
Eleonora Cunto
Publication year - 2018
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2018.04.4063
Subject(s) - medicine , intensive care unit , pneumonia , mechanical ventilation , univariate analysis , hypoalbuminemia , incidence (geometry) , mortality rate , pneumothorax , apache ii , surgery , multivariate analysis , physics , optics
Purpose Pneumocystis jirovecii pneumonia (PJP) has historically been one of the leading causes of disease among persons with Aids. The introduction of highly active antiretroviral therapy has brought about dramatic declines in the incidence of Aids-associated complications. However, HIV-infected patients (HIP) who ignore their HIV status or those without viral suppression, may develop PJP and require admission to an intensive care unit (ICU), with a mortality rate of ICU HIV patients with PJP can still be up to 60% (1,2). Our aims are to describe clinical characteristics of patients with proven Aids-related PJP and determine factors related with mortality
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom